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Pulmonary arteriovenous malformations (PAVMs) are a
known complication after cavopulmonary shunt operations.1
Their cause is unknown, but they may be related to the
absence of pulsatile flow, the diversion of hepatic venous
flow away from the pulmonary circulation, or other humoral
factors.2 By shunting a large amount of unoxygenated blood
across the lungs, PAVMs cause cyanosis and may make sub-
sequent operations riskier. However, there is a paucity of data
related to the latter subject. We describe the postoperative
course of 3 recent patients with multiple PAVMs, cyanosis,
and complex congenital heart disease (CHD).
Clinical summaries 
PATIENT 1. A 2-year-old boy had corrected transposition of
the great arteries, pulmonary atresia, ventricular septal defect,
and a small morphologically right ventricle. He had under-
gone bilateral modified Blalock-Taussig shunts with subse-
quent takedown and conversion to a bidirectional cavopul-
monary shunt at the age of 8 months at an outside institution.
Preoperative cardiac catheterization showed multiple PAVMs
in the right lower lobe. He underwent a 1.5-ventricle repair
with an intracardiac left ventricle–aorta baffle and a right
ventricle–pulmonary artery conduit with baffling of the infe-
rior vena cava to the tricuspid valve. The cavopulmonary
shunt was left in place. After discontinuation of cardiopul-
monary bypass, the hemoglobin saturations were in the 80s.
Over the next 12 hours, the saturations steadily fell with
ensuing metabolic acidosis and worsening left ventricular
function. Extracorporeal membrane oxygenator (ECMO) sup-
port was begun, and he was taken to the catheterization labo-
ratory where a balloon catheter was inserted into the right
lower lobe branch and partially inflated to impede flow and
improve oxygenation. With the oxygenator off, the oxygen
saturation immediately improved from the low 50s to the
high 80s. The balloon catheter was left in place and he was
weaned from mechanical support on postoperative day 2. The
balloon was left inflated for 4 days and was slowly deflated
over a period of several days, maintaining oxygen saturation
in the high 70s. He was extubated on postoperative day 23
and was discharged to his home on postoperative day 41.
PATIENT 2. A 4-year-old girl had single right ventricle, trans-
position of the great arteries, and mitral and pulmonary atre-
sia with discontinuous pulmonary arteries. She underwent
bilateral modified Blalock-Taussig shunts at 2 weeks of age
and a cavopulmonary shunt with pulmonary arterioplasty at 8
months of age. She became progressively hypoxemic. Cardiac
catheterization showed development of extensive right
PAVMs with a pulmonary venous saturation of 41% with the
child breathing room air. There were multiple aortopulmonary
collaterals. A lateral-tunnel Fontan procedure was performed
with an intra-atrial patch baffle. A baffle fenestration was not
created because it was believed that the PAVMs would effec-
tively act as a fenestration. Postbypass hemoglobin saturations
were around 60%. The patient became coagulopathic and a
low cardiac output state developed within hours of her return
to the intensive care unit. Catheterization showed a large num-
ber of tiny collateral vessels that were unsuitable for coiling.
A large amount of blood was seen flowing into the PAVMs.
Heparinization and balloon occlusion were contraindicated
given the persistent coagulopathy, hemodynamic instability,
and diffuse nature of the PAVMs. The oxygen saturations
remained in the 50s and she died on postoperative day 1.
PATIENT 3. A 23-month-old girl had heterotaxia syndrome
with polysplenia, dextrocardia, interrupted inferior vena cava
with azygos continuation, and complete atrioventricular sep-
tal defect. She underwent pulmonary artery banding at 2
weeks of age and a cavopulmonary shunt (Kawashima proce-
dure) at 4 months. She had recently had progressive arterial
desaturation, and catheterization demonstrated multiple
PAVMs in both lungs, as well as poor biventricular function.
She underwent orthotopic heart transplantation. She was
weaned from bypass in a desaturated state but without signif-
icant hemodynamic difficulties. She became progressively
hypoxemic early after the operation, with saturations in the
50s. This progressed to severe biventricular dysfunction, and
ECMO support was begun. Catheterization with the ECMO
turned on and off showed very rapid transit through the lungs
as evidence that the PAVMs were contributing significantly to
her profound cyanosis. She was weaned from the ECMO
after 5 days but remained cyanotic, with saturations in the
70s. In an attempt to improve her ventilation/perfusion mis-
match, we began administering inhaled nitric oxide at a dose
of 10 ppm. Her saturations improved dramatically into the
90s. Several hours later, she became gradually more hypox-
emic, and the nitric oxide dose was increased to 20 ppm with
a resultant increase in saturation. She then made a slow
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recovery, and we were able to slowly discontinue the nitric
oxide over a period of 14 days. She was eventually discharged
to her home.
Discussion. The purpose of this report is to draw attention
to the fact that PAVMs can be the source of significant mor-
bidity after operations for complex CHD and to discuss
potential therapeutic maneuvers. Children who undergo a
cavopulmonary shunt should be monitored closely since it is
impossible to predict the development of PAVMs. PAVMs are
known to regress after the Fontan procedure or after heart
transplantation.3,5 Ideally, patients who seem to have a pre-
disposition to rapid formation of PAVMs should undergo an
early Fontan procedure. Prophylactic embolization is not
always feasible given the usual diffuse nature of the PAVMs
and the attendant complications of embolization.4 The com-
mon clinical feature in this group of patients is the occurrence
of profound cyanosis nearly immediately after the operation,
progressing to multiple organ dysfunction. ECMO is an ideal
method to restore oxygenation but does not reverse the right-
to-left shunt across the PAVMs seen in all patients. After the
initial success with balloon occlusion in patient 1, the idea
was entertained in patients 2 and 3. In patient 2, the diffuse
nature of the PAVMs made this invasive technique less likely
to succeed. For patient 3, ECMO was used as a supportive
measure for hemodynamic instability and cyanosis. However,
a period of 5 days on ECMO did not seem to be sufficient to
allow normal lung parenchyma to recover, even though
myocardial function had recovered fully. Inhaled nitric oxide
proved to be a very effective rescue treatment, allowing for
redistribution of pulmonary blood flow away from the
PAVMs in a now hemodynamically stable patient. To our
knowledge, none of the described maneuvers has been report-
ed in this setting in the literature. Because they are available
to most physicians caring for children with complex CHD,
they can be easily instituted. Furthermore, the presence of
PAVMs, although an important risk factor, should not be con-
sidered a contraindication to reconstructive surgery or trans-
plantation.
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